Antonella Consiglio

Identification of differential biological activity and synergy between the PARP inhibitor rucaparib and its major metabolite.

M. Pujana, A. Antolin, I. Fernandez-Carasa, 2024, Cell chemical biology.

Blocking IL-6 signaling prevents astrocyte-induced neurodegeneration in an iPSC-based model of Parkinson’s disease

L. Espinosa, L. Blasco-Agell, P. Andrés‐Benito, 2024, JCI insight.